CURRICULUM VITAE - University of Illinois College of Medicine at ...

Mehdi Seyed Mirsaeidi 

Division of Pulmonary and Critical Care, Department of Medicine, 

University of Illinois at Chicago  840 S. Wood St.Chicago, IL 60612-7323 

Cell: 240- 383-7539 E-mail: golmeh@yahoo.com; mmirsae@uic.edu 

EDUCATION 

CURRICULUM VITAE 

1998-1999 Master of Public Health 

University of Tehran 

Tehran, Iran 

1986-1993 Doctor of Medicine 

University of Qazvin 

Iran 

1982-1986 Shariati High School 

Iran 

PROFESSIONAL TRAINING 

07/2011- present Pulmonary & Critical Care fellowship 

Division of Pulmonary & Critical Care, 

Department of Medicine, 

University of Illinois in Chicago, 

Chicago, IL, USA 

7/2008- 06/2011 Internal Medicine Residence, 

Department of Internal Medicine , 

Providence Hospital, George Washington University, 

Washington, DC, USA 

4/2007 – 7/2008 Infectious Diseases Research Fellowship 

Division of Infectious Diseases, University of Louisville 

Louisville, Kentucky, USA 

5/2006 –3/2007 Postdoctoral Fellow 

Pediatric Sleep Medicine & Neuroscience, University of Louisville 

Louisville, Kentucky, USA 

1998-2002 Infectious Diseases Residency 

Division of Infectious Diseases, University of Shaheed Beheshti

Tehran, Iran. 

Licensure and Board Certifications: 

1) Medical license in Illinois # 036-127946 

Board certified of American Board of Internal Medicine 2011 valid through 2021. 

2) Permanent board certified of Infectious Diseases from Department of Health of 

Iran since 2001. 

PREVIOUS APPOINTMENT 

2002-2006 Assistant Professor of Medicine 

Shaheed Beheshti Medical Science University 

Tehran, Iran 

ADMINISTRATIVE POSITIONS 

2012-present Member of International Health Committee of American Thoracic 

Society (ATS) 

2007-present The Genetic Association Database expert in the 

Tuberculosis disease and IFN-gamma R1 & mt-DNA 

genes, CDC, NIH 

2005-2006 Turbeculosis Expert, Research & Planning Deputy 

National Tuberculosis Program 

Center of Disease Control (CDC), Health Ministry,Iran 

2003-2006 Director Clinical Research Committee, National Research Institute 

of Tuberculosis and Lung Disease,Tehran, Iran 

2002-2005 Head of Tuberculosis & Respiratory Infections Unit 

Infectious Diseases and Clinical Immunology Department, 

National Research Institute of Tuberculosis and Lung Disease, 

Tehran, Iran 

2002-2005 General Secratory of Clinical Research Group 

National Research Institute of Tuberculosis and Lung Disease 

Tehran, Iran 

2003- 2005 Director of Physical Diagnostic Program in Medicine Faculty 

2

Shaheed Beheshti Medical Science University 

Tehran, Iran 

2001-2004 Educational director of Internal Medicine Internship, National 

Research Institute of Tuberculosis and Lung Disease, Tehran, Iran 

2001- 2005 Lecturere in several WHO courses for TB and HIV for Middle East 

conteries experts 

PROFESSIONAL AFFILIATIONS 

2011- present Membership in American Thoracic Society 

2008- present Membership in American Collage of Physician 

2005—2006 Membership in International AIDS Society 

2003—2006 Membership in European Respiratory Society 

2001—present Membership of Iranian Infectious Diseases Society 

2001-present Membership of Iranian Internal Medicine Society 

2005-present Membership of Oxford Health Alliance. (This membership is based 

of my research activity about Tobacco and Tuberculosis that was 

presented in 4th Annual Global Health Research Conference, 

March 2006, Toronto University, Canada 

2004- Present Membership in The Science Advisory Board. This is a global 

community of life scientists. 

2004-Present Expert Columnists of Sociedad Iberoamericana de Informacion 

Cientifica (SIIC). Buenos Aires, Argentina. 

Editorial board and reviewer of peer-reviewed journals 

1. International Journal of Mycobacteriology (Editorial Board) 

Journal of Infectious Disease in Developing Country (Past-Editorial Board) 

2. International Journal of Tuberculosis and Lung Diseases (Reviewer) 

3. Journal of Respiratory (Reviewer) 

4. Journal of Respiratory Medicine (Reviewer) 

5. Saudi Medical Journal (Reviewer) 

6. Archives of Iran Medicine (Reviewer) 

7. International Journal of Biomedical Science (IJBS, ISSN 1550- 9702) (Reviewer) 

8. Journal of Women's Health (Reviewer) 

9. Lung (Reviewer) 

10. Journal of Antimicrobial Chemotherapy (Reviewer) 

11. Annals of American Thoracic Society ( Reviewer) 

Active Projects: 

1) Role: PI 

3

Protocol title: Treatment Outcomes in Patient with Nontuberculous 

Mycobacterial Disease in the University of Illinois Hospital & Health 

Sciences System. 

Protocol number: 2012-0662 

2) Role: Co-Investigator , PI: Dr. Skip Garcia 

Protocol title: Biomarkers of Health and Disease 

Protocol number: 2010-0191 

3) Role: Co-Investigator , PI: Dr. Dean Schraufnagel 

Protocol title: Bronchiectasis Research Registry: A Consolidated Database of 

Non-Cystic Fibrosis Bronchiectasis Patients from Major Clinical and 

Research Institutions. Protocol number: 2008-0845 

PUBLICATIONS 

International Peer-Review Journals 

1. Farnia P, Mohammadi F, Mirsaedi M et al. Bacteriological follow-up of pulmonary 

tuberculosis treatment: a study with a simple colorimetric assay, Microbes Infect; 

6(11):972-6, 2004. 

2. Farnia P, Mohammadi F, Mirsaedi M et al. Application of oxidation-reduction 

assay for monitoring treatment of patients with pulmonary tuberculosis, J Clin 

Microbiol. 42(7):3324-5, 2004. 

3. SM. Mirsaeidi, P. Tabarsi, M.O. Edrissian, et al. Primary multi-drug resistant 

tuberculosis presented as lymphadenitis in a patient without HIV infection, Monaldi. 

Arch. Chest. Dis. 61:244-247, 2004. 

4. Guillaume Vogt, Ariane Chapgier, Kun Yang, Nadia Chuzhanova, Jacqueline 

Feinberg, Claire Fieschi, Stéphanie Boisson-Dupuis, Alexandre Alcais, Orchidée Filipe- 

Santos, Jacinta Bustamante, Ludovic de Beaucoudrey, Ibrahim Al-Mohsen, Sami Al- 

Hajjar, Abdulaziz Al-Ghonaium, Parisa Adimi, Mehdi Mirsaeidi, Soheila Khalilzadeh, 

Sergio Rosenzweig, Oscar de la Calle Martin, Thomas R Bauer, Jennifer M Puck, Hans D 

Ochs, Dieter Furthner, Carolin Engelhorn, Bernd Belohradsky, Davood Mansouri, Steven 

M Holland, Robert D Schreiber, Laurent Abel, David N Cooper, Claire Soudais & Jean- 

Laurent Casanova. Gains of glycosylation comprise an unexpectedly large group of 

pathogenic mutations. Nat. Genet.37:692-700, 2005. 

5. Mirsaeidi SM, Tabarsi P, Amiri M, et al. Hematologic abnormalities observed in 

pulmonary tuberculosis, SIIC´s Journal Salud(i)Ciencia.13:23-26, 2005. 

http://www.siicsalud.com/dato/dat043/05530010.htm. 

4

6. Mansouri D, Adimi P, Mirsaeidi M, et al. Inherited disorders of the IL-12-IFNgamma 

axis in patients with disseminated BCG infection. Eur. J. Pediatr.164: 753-7, 

2005. 

7. Mansouri D, Adimi P, Mirsaedi M, et al. Primary immune deficiencies presenting 

in adults: seven years of experience from Iran. J. Clin. Immunol. 2005; 25: 385-91. 

8. Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, 

Mansoori SD, et al. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in 

Iran . Int. J. Infect. Di. 9:317-22, 2005. 

9. Mirsaeidi SM, Houshmand M, Tabarsi P, Banoei MM, Zargari L, Amiri M. Lack of 

association between interferon-gamma receptor-1 polymorphism and pulmonary 

TB in Iranian population sample. J. Infect. 52:374-7, 2006. 

10. Tafti SF, Tabarsi P, Mansouri N, Mirsaeidi M, Motazedi Ghajar MA, Karimi S, 

Najar HM, Mansouri D. Chronic Granulomatous Disease with Unusual Clinical 

Manifestation, Outcome, and Pattern of Inheritance in an Iranian Family. J. Clin. 

Immunol. 26 291-6, 2006. 

11. Farnia P, Masjedi MR, Mirsaeidi M, Mohammadi F, Jallaledin-Ghanavi, Vincent V, 

Bahadori M, Velayati AA. Prevalence of Haarlem I and Beijing types of 

Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients. J 

Infect. 53:331-6, 2006. 

12. Fateminasab FD, Shahgasempour S, Mirsaeidi SM, Tabarsi P, Mansoori SD, 

Entezami Z. Increased activation and expansion of a CD57+ subset within peripheral 

CD8+ T lymphocytes in Mycobacterium tuberculosis-infected patients. Arch. Iran. 

Med. 9:53-7, 2006. 

13. Ali Akbar Velayati, Parissa Farnia, Mehdi Mirsaeidi, and Mohammad Reza Masjedi, 

The most prevalent Mycobacterium tuberculosis superfamilies among Iranian and 

Afghan TB cases. Scand. J. Infect. Dis. 38:463-8, 2006 

14. Mirsaeidi SM, Tabarsi P, Mardanloo A, Amiri M, Farnia P, Sheikhleslami M et al. 

Pulmonary Mycobacterium Simiae infection &HTLV1 infection: an incidental coinfection 

or a predilection factor? Monaldi. Arch. Chest. Dis. 2006; 65:106-9. 

15. Rashid Ramazanzadeh, Parissa Farnia, Nour Amirmozafari, Farid Ghazi, Zeinab 

Ghadertotonchi, Jaber Kameran, Froozan Mohammadi, Mehdi Mirsaeidi, 

Mohammadreza Masjedi. Comparison between Molecular Epidemiology, 

Geographical Regions and Drug Resistance in Mycobacterium tuberculosis Strain 

Isolated from Iranian and Afghan Patients. Chemotherapy. 52:316-20, 2006. 

5

16. P. Tabarsi, D. Mansouri, O Edrissian, A. Alaei,M. Amiri and S. M. Mirsaeidi. 

Perianal tuberculosis in an HIV-positive patient. East. Mediterr. Health. J. 12:923-6, 

2006. 

17. P. Farnia, M. R. Masjedi, B. Nasiri, M. Mirsaeidi, S. Sorooch, M. Kazeampour and 

A. A. Velayati.. Instability of IS6110 patterns in multidrug-resistant strains of 

Mycobacterium tuberculosis. Epidemiol Infect. 135:346-52, 2007. 

18. Mehdi S. Mirsaeidi, Payam Tabarsi, Parissa Farnia, Golnaz Ebrahimi et al. Trends 

of drug resistant m. tuberculosis in a tertiary tuberculosis center in Iran. Saudi Med 

J. 24(4):544-550, April, 2007. 

19. Mirsaeidi MS, Tabarsi P, Radpour O, Mansouri D, Amiri M, Bagheri Z, et al. 

Differences in characteristics between Afghani and Iranian patients with pulmonary 

tuberculosis. Int J Infect Dis. 2007 Mar; 11(2):180-2 

20. Mirsaeidi SM, Baghernia A, Tabarsi P, Amiri M, Mansouri SD, Masjedi MR, 

Velayati AA. From the First Symptom to the First Visit and From Visit to Definite 

Diagnosis of Pulmonary TB Still a Long Delay. Arch Iran Med. 10(2):190-3. April, 

2007 

21. Mirsaeidi SM, Masjedi MR, Mansouri SD, Velayati AA. Tuberculosis of the 

breast: Report of four clinical cases and literature review. East. Mediterr. Health. J. 

13(3):670-6. May, 2007 

22. Houshmand M, Banoei MM, Tabarsi P,(…)and Mirsaeidi M. Do Mitochondrial 

DNA Haplogroups play a role in susceptibility to Tuberculosis? Respirology 2007; 

12: 823-7 

23. Tabarsi P, Baghaei P, Mirsaeidi M, et al. Multi-drug resistant tuberculosis in 

pregnancy: need for more intensive treatment. Infection 2007; 35:477-8. PMID: 

17906837 

24. Tabarsi P, Mirsaeidi M, Karimi S, Banieghbal B, Mansouri N, Masjedi MR, 

Mansouri D. Lymphocytic bronchiolitis as presenting disorder in an undiagnosed 

adult patient with chronic granulomatous disease. Iran J Allergy Asthma Immunol. 

2007; 6:219-21 PMID: 18094446 

25. Javadi MR, Shalviri G, Gholami K, Salamzadeh J, Maghooli G, Mirsaeedi SM. 

Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity 

and risk factors. Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1104-10 PMID: 

17823987 

26. Tabarsi P, Baghaei P, Mirsaeidi M, Amiri M, , Alipanah N, Emami H, , Novin A, 

Mansouri D, Masjedi MR, Velayati AA. Treatment outcome of tuberculosis patients 

6

diagnosed with human immunodeficiency virus infection in Iran. Saudi Med J. 2008 

Jan;29(1):148-50 PMID: 18176695 

27. Tabarsi P, Nooraki A, Mirsaeidi M, Amiri M, Baghaei P, Farnia P, Kazempour M, 

Heidarnezhad H, Alipanah N, Mansouri D, Masjedi MR. Representative drug 

susceptibility patterns for guiding design of re-treatment regimens for multidrugresistant 

tuberculosis in Iran. Respirology; 2008: 13, 108–111 PMID: 18197919 

28. Payam Tabarsi, Parvaneh Baghaei, Parisa Farnia, Amir Hoseyn Radaei, 

MehdiKazempour, Yazdan Ali Faghani, Mehdi Mirsaeidi,Atieh Novin1,Hasan 

Heidarnegad,Davoud Mansouri, Mohammad Reza Masjedi Outcome of Treatment of 

MDR-TB Patients with Standardized Regimens; Iran’s Experience 2002-2006. The 

Int J Tuberc Lung Dis. 2008 Jul;12(7):750-5. PMID: 18544199 

29. Julio Ramirez , Stefano Aliberti , Mehdi Mirsaeidi , Paula Peyrani , Giovanni 

Filardo , Asad Amir , Bryan Moffett, Joshiah R Gordon, Francesco Blassi and Jose 

Bordon .Acute Myocardial Infarction in Patients with Community-Acquired 

Pneumonia. Clin Infect Dis. 2008 Jun 5 PMID: 18533841 

30. Stefano Aliberti , Asad Amir , Paula Peyrani, Mehdi Mirsaedi, Raul Nakamatsu, 

Forest Arnold , Marty Allen , Brian Moffett , John Myers , Fidaa H Shiba , Maria Cirino , 

Jose Bordon, Francesco Blasi and Julio A Ramirez .INCIDENCE, ETIOLOGY, 

TIMING AND RISK FACTORS FOR CLINICAL FAILURE IN HOSPITALIZED 

PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. Chest PMID: 

18583514 

31. Tabarsi P, Mirsaeidi SM, Amiri M, et al.Clinical and laboratory profile of patients 

with tuberculosis/HIV coinfection at a national referral centre: a case series. East 

Mediterr Health J. 2008 Mar-Apr;14(2):283-91 PMID: 18561719 

32. Farnia P, Masjedi MR, Varahram M, Mirsaeidi M, Ahmadi M, Khazampour M, 

Tabarsi P, Baghei P, Marjane M, Bahadori M, Zarifi AH, Velayati AA. The Recent- 

Transmission of Mycobacterium tuberculosis Strains among Iranian and Afghan 

Relapse Cases: a DNA-fingerprinting using RFLP and spoligotyping. BMC Infect 

Dis. 2008 Aug 6;8(1):109 PMID: 18681980 

33. Tabarsi P, Mirsaeidi M, Amiri M, et al. Inappropriate use of steroid and 

pneumocystis Jiroveci pneumonia: Report of two cases. East Mediterr Health J. 2008 

Sep-Oct;14(5):1217-21 

34. Tabarsi P, Baghaei P, Jalali S, Farnia P, Chitsaz E, Mirsaeidi M, Kazempour M, 

Mansouri D, Masjedi MR, Velayati AA. Is standardized treatment appropriate for 

non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study. 

Scand J Infect Dis. 2008 Nov 26:1-4; PMID: 19037820 

7

35. Tabarsi P, Baghaei P, Farnia P, Mansouri N, Chitsaz E, Sheikholeslam F, Marjani M, 

Rouhani N, Mirsaeidi M, Alipanah N, Amiri M, Masjedi MR, Mansouri D. 

Nontuberculous mycobacteria among patients who are suspected for multidrugresistant 

tuberculosis-need for earlier identification of nontuberculosis 

mycobacteria. Am J Med Sci. 2009 Mar;337(3):182-4. PMID: 19301453 

36. Masoud Shamaei, Majid Marjani, Ehsan Chitsaz, Mehdi Kazempour,Mehdi Esmaeili, 

Parisa Farnia, Payam Tabarsi,Majid V Amiri , Mehdi Mirsaeidi, Davood Mansouri, 

Mohammad R Masjedi, Ali A Velayati. First-line anti-TB Drug Resistance Pattern 

and Its Trend in the National TB Referral Center in Iran-Eight Years of 

Surveillance. Int J Infect Dis. 2009 Sep; 13(5):e236-40 PMID: 19285897 

37- Mirsaeidi M, Peyrani P, Ramirez JA; Improving Medicine through Pathway 

Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) 

Investigators. Predicting Mortality in Patients with Ventilator-Associated 

Pneumonia: The APACHE II score versus the new IBMP-10 score. Clin Infect Dis. 

2009 Jul 1;49:72-7 PMID: 19480582 

38. Seyed Mehdi Mirsaeidi , Mohammad Mehdi Banoei , Massoud Houshmand , Payam 

Tabarsi ,Laleh Zargari , Golnaz Ebrahimi , Baharak Houshiar Kashani , Amiri A., Seyed 

Davoud Mansouri, Mohammad Reza Masjedi . Vitamin D receptor homozygote 

mutant tt and bb are associated with susceptibility to pulmonary tuberculosis in the 

Iranian population. Int J Infect Dis. 2009 May 29. PMID: 19482503 

39- Mehdi Mirsaeidi , Stefano Aliberti , Paula Peyrani , Giovanni Filardo , Bryan 

Moffett, Joshiah R Gordon , Julio Ramirez. Thrombocytopenia and Thrombocytosis at 

Time of Hospitalization Predict Mortality in Patients with Community-Acquired 

Pneumonia. Chest 2009 Oct 16. PMID: 19837825 

40- Merza M, Farnia P, Anoosheh S, Varahram M, Kazampour M, Pajand O, Saeif S, 

Mirsaeidi M, Masjedi MR, Velayati AA, Hoffner S. The NRAMPI, VDR and TNFalpha 

gene polymorphisms in Iranian tuberculosis patients: the study on host 

susceptibility. Braz J Infect Dis. 2009 ;13:252-6. PMID: 20231985 

41- Tabarsi P, Baghaei P, Hemmati N, Mirsaeidi M, Kazempour M, Mansouri D, 

Masjedi MR. Comparison of the effectiveness of 2 treatment regimens in patients 

with isoniazid-resistant tuberculosis. East Mediterr Health J. 2009 Nov- 

Dec;15(6):1346-50. 

42. Aliberti S, Peyrani P, Filardo G, Mirsaeidi M, Amir A, Blasi F, Ramirez JA. 

ASSOCIATION BETWEEN TIME TO CLINICAL STABILITY AND 

OUTCOMES AFTER DISCHARGE IN HOSPITALIZED PATIENTS WITH 

COMMUNITY-ACQUIRED PNEUMONIA. Chest. 2011 140(2):482-8. PMID: 

21330383 

8

43. Mirsaeidi M, Bordon J. Generalized lymphadenopathy with cystic spleen 

lesions: a rare presentation of tuberculosis. Int J Infect Dis. 2011 Jul;15(7):e505. 

PMID: 21555230 

44. Baghaei P, Tabarsi P, Farnia P, Radaei AH, Kazempour M, Faghani YA, Mirsaeidi 

M, Novin A, Chitsaz E, Mansouri D, Masjedi MR, Velayati AA.Utility of Gastric 

Lavage for Diagnosis of Tuberculosis in Patients who are Unable to Expectorate 

Sputum. J Glob Infect Dis. 2011 Oct;3(4):339-43. 

45.Mirsaeidi M. Rifapentine and Isoniazid for Latent Tuberculosis Infection 

Treatment (letter), NEJM. 

46. Mirsaeidi M. Personalized medicine approach in mycobacterial disease. 

International Journal of Mycobacteriology. Available online 9 May 2012 

47. Arnold FW, Wiemken T, Peyrani P, Mirsaeidi M, Ramirez JA; for the CAPO Study 

Group. Outcomes in females hospitalised with community-acquired pneumonia are worse 

than males. Eur Respir J. 2012 Jul 26. PMID: 22835618 

48. Mirsaeidi, Mehdi; Syed, Fatima; Jaffe, Elaine S. Antineutrophil Cytoplasmic 

Autoantibody-Associated Systemic Vasculitis is Associated With Epstein-Barr Virus 

in the Setting of HIV. Infection Infectious Diseases in Clinical Practice: , 8 August 

2012. doi: 10.1097/IPC.0b013e3182601ea1 

Persian & English Domestic Peer Review Journals 

1. Mirsaeidi SM, Jabbar Darjani HM, Farnia P, Mansouri SD, Taghizadeh ASL R. First 

line anti-tuberculosis drug resistance in Mycobacterium kansasii and other nontuberculosis 

mycobacteria, a comparative study. Iranian Journal of infections Disease 

and Tropical Medicine. 20:22-9, 2003. (Persian language) 

2. S. Zahirifard, M.V. Amiri, M. Bakhshayesh Karam, S.M. Mirsaeidi, A. Ehsanpour, 

M.R. Masjedi, The Radiological Spectrum of Pulmonary Multidrug-Resistant 

Tuberculosis, Iran. J. Radiol. 1-6, December, 2003; (English language): Accessible at: 

http://diglib.tums.ac.ir/pub/magmng/pdf/261.pdf 

3. Mirsaeidi SM, Mansouri SD. Epidemiology and treatment of infection following 

lung transplantation, Gashtak periodical. 31-32;28-9, 2002. (Persian language) 

4. Mirsaeidi SM, Yadegari D. Epidemiological survey of a cholera patient in Shaheed 

Beheshti University of Medical Sciences. Iranian Journal of infections Disease and 

Tropical Medicine, 3, 1997. (Persian language) 

5. Mirsaeidi S.M, Shah Ghasempour S, Amiri M, Etal, Boloursaz, Kazempour M, 

9

Mohammadi F, Mansoori Velayati. Lmphocyte sub- populations and lymphocyte 

activation markers in pulmonary TB patients, Tanaffos, (Respiration),1: 37-42, 2002. 

(English language): Accessible at: 

http://www.tanaffosjournal.ir/full_article.asp?article_code=3&mag=1%20_%204%20_% 

202002 

6. Aminzadeh Z, Mirsaeidi S.M, Kazempour M, Mansuri S.D, Masjedi MR, Valiollapour 

M, Cutaneous Anegry in patients receiving long term hemodialysis, Tanaffos 

(respiration). 1:21-25, 2002. (English language) Accessible at: 

www.tanaffosjournal.ir/prv_issues.asp?item=magazine&period=1&mag_no=2&publishy 

ear=2002 

7. Mirsaeidi S.M, Sohrabpour S, Mansuri S.D, Tavana S, Yaazdanpanah M, The 

efficacy of interferon - in the Treatment of multidrug resistant Tuberculosis, 

Tanaffos (respiration).3:29-33, 2002. (English language) 

8. Mirsaeidi S M, Hashimim, Rafiey, Kashoofi,Kzempour, Masjedi m, A Comparison 

Between the MMPI 2- Profile in Tuberculosis and Other Pulmonary Disease. 

Tanaffos (Respiration).2:34-43, 2003. (English language) 

9. Mirsaeidi SM, Tabarsi P, Amiri M, Mansoori S.D, Bakhshayeshkaram M, Masjedi 

M.R, Velayati AA. Clinical and Radiological Presentation of Adult Tuberculosis, 

Spondylitis. Tanaffos (Respiration).6:59-65, 2003. (English language) Accessible at: 


202003 

10. Mirsaeidi SM, Zareiy S, Mansouri SD, Tabarsi P, Valioallahpour a, Kazempour M, 

Masjedi, Velayati A. Lymphocytopenia as a Mortality Predictor in Non-HIV 

Pulmonary TB Patients. Tanaffos (Respiration).2:25-31, 2003. (English language) 

Accessible at: 


202003 

11. Valiollahpour A, Mirsaeidi SM, Mohajer K, Mansoori SD, Tabarsi P, Masjedi M, 

Pattern of Drug Resistance in Pulmonary TB Patients. Tanaffos. 2:47-51, 2003. 

(English language) Accessible at: 


202003 

12. Boloursaz SD, Milanifar AR, Khalilzadeh S, Kazempour M, Masjedi H, Mirsaeidi 

SM, Farnia P, Masjedi M, Velayati A, The Positive Effect of Oral Zinc Sulphate on 

Sputum Conversion of Patients with Pulmonary Tuberculosis. Tanaffos. 2:53-60, 

2003. (English language) Accessible at: 


202003 

10

13. Jamaati HR, Mansouri SD, Zahedpour MR, Mirsaeidi SM, Kazempour M, Eskandari 

M, Contributing Factors in Anti- Tuberculosis Treatment Failure, Tanaffos. 2,7,61- 

68, 2003. (English language) Accessible at: 


202003 

14. Darjani J, Mirsaeidi SM, Mir- Afsharieh A,Edrissian M, Haghighi SH, Dilemma in 

Management of Diabetic Patients with Pulmonary Mucormycosis. Tanaffos. 2:69-77, 

2003. (English language) 

15. Zahirifard S. Amiri V, Bakhshayeshkaram M, Mirsaeidi S.M, Ehsanpour A, Masjedi 

M, The radiological Spectrum of Pulmonary Multidrug –Resistant Tuberculosis in 

HIV – Negative Patients. Iranian Journal of Radiology.1:161-7, 2003. (English 

language) Accessible at: http://www.ijr.ir/index_files/page0006.htm 

16. Shekaraby M, Miyandehi N, Mansoori SD, Tavasoly M, Alibahar M, Amirkhany M, 

Mirsaeidi SM. The study of TH1/TH2 cytokine profiles (il-10, il-12, il-4 IFN-γ) in 

PBMCs of patients with multidrugresistant tuberculosis and newly diagnosed drug 

responsive cases. Tanaffos, 2005. (English language) 

17. Mehrdad Bakhshayesh-Karam, Payam Tabarsi, Seyed Mehdi Mirsaiedi, Majid 

Valiollahpour Amiri, Soheila Zahirifard, Seyed Davood Mansoori, et al. Radiographic 

Manifestations in TB/ HIV Patients. Tanaffos. 3:158-64, 2004. (English language) 

Accessible at: 


202004 

18. Mohamadian S, Baghdadchi J, Ostad Rahimi AR, Shahghasempour Sh, Valiollahpour 

Amiri M, Mohammadi F, Mirsaeidi SM, Velayati AA. Vitamin A Supplementary 

Effect on Immunologic Profiles in Tuberculosis Patients. Tanaffos. 9 53-60, 2005. 

(English language) 

19. Iraj Nikokar, Manouchehr Makvandi, Mohammad Javad Kajbaf, Ahmad Farajzadeh, 

Medhi Mirsaeidi, Eskandar Kamali-Sarvestani et al. Evaluation of Cellular Immune 

Response against Purified Antigen 85 in Patients with Tuberculosis. Iran J. Immunol. 

3:70-7, 2006. (English language) Accessible at: 

http://iji.sums.ac.ir/spring2006/4thiji_vol3_no2_2006.pdf 

20. Tabarsip P. Mirsaeidi S.M., Amiria M., Baghaie P., Mansoori S.D., Masjedi M.R., 

Velay Ati A.A., Respiratory manifestation of TB/HIV patients in a referral center. 

Iranian Journal of Infectious Diseases and Tropical Medicine. 11(33):49-54, June, 2006. 

(Persian language) 

21. Fallah Tafti S., Marashian M., Kazempour Dizaji, Mirsaedi S.M., Short outcome 

and evaluation of hemoptysis in patients with old pulmonary TB. Tanaffos. 4(15):43- 

48, 2005. (English language) 

11

22. Behzadnia N., Sharif Kashani B., Tabarsi P., Mirsaeidi S.M., Valiollahpour Amiri 

M., Alvanpour A., Mansoori S.D., Evaluation of patients with infective endocarditis in 

a pulmonary referral centre. Tanaffos. 4(16):41-45, 2005. (English language) 

23. Tabarsi P., Mirsaeidi S.M., Valioallahpour Amiri M., Mansouri S.D., Bakhshayesh 

Karam M., Ghasempour S.H., Zargari L., Farnia P., Mohammadi F., Kazempour M., 

Aelai A., Masjedi M.R. Velayati A.A., Evaluations of Clinical and Laboratory 

Charactersitics of TB/HIV patients in Masih Daneshvari Hospital. Hakim 8(1):1-7, 

2005. (Persian language) 

Articles Accepted for Publication 

1. Mehdi Mirsaeidi MD MPH, Fatima Syed MD, Michael Brancaccio MD, Jose 

Bordon MD, James Roberson II MD, Abrahim Dabela MD and Elaine Jaffe MD. 

Antineutrophil Cytoplasmic Autoantibody (ANCA)-Associated Systemic Vasculitis 

(AASV) Is Associated with Epstein - Barr virus in The Setting of HIV Infection. 

Manuscript submitted for publication 

1. Non-tuberculous mycobacterial disease is common in patients with Non-Cystic 

Fibrosis bronchiectasis. International Journal of Infectious Diseases 

2. After 40 Years, New Medicine for Combating TB. International Journal of 

Mycobacteriology 

3. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of 

Refractory Sarcoidosis. Chest 

AWARDS, HONORS and Grants 

12

2008 Awarded by Veterans Health Administration, Research 

Development, Louisville, for service to veterans and the nation 

as a volunteer and participant in VA healthcare research. 5-9- 

2008 

2008 Selected to be indexed in upcoming 63rd (2009) Edition of 

Who'sWho in America 

2007 Awarded by Executive Vice President for Health Affairs for 

participation as a judge of the poster competition in Research! 

Louisville 2007 

2004 Awarded by Iranian Ministry of Health, Treatment & Medical 

Education scientific for efforts in combating (Clinical Care and 

research) with tuberculosis on the Country. [This award is the 

highest prestigious award in the field of Tuberculosis that is 

awarded in TB National Day ] 

2004 Awarded by Pakistani Chest Society for academic contributions 

and important researches in the 6 th Biennial Conference on 

Tuberculosis & Lung disease. 12-15 March Karachi, Pakistan 

2002 Awarded by director of Labbafi-Nejad medical Complex in 

Tehran, Iran for first Ranking in the Board examination of 

Infectious disease & Tropical Disease in Shaheed Beheshti 

University of Medical Sciences, Tehran, Iran 

2002 Awarded by Iranian State Organization of Welfare Cultural & 

Prevention Affairs Deputy for scientific contributions in Medical 

Counseling training courses in two sessions and each one two 

weeks. I delivered lecture about immunogenetic disorders 

particularly Primary immunodeficiency. Also, I spoke about 

genetic base in some cancers like Lung cancer. 

2002 Travel grant (Flight + accommodation +Registration fee) from 

Federation of Clinical Immunology Societies, 2nd Annual 

Meeting, June 28-July 1 , San Francisco,CA 

2003 Travel grant (Accommodation +Registration fee+ per diem) from 

European Respiratory Society (ERS) to present abstracts in 13 th 

Annual Congress, Vienna 27 September- 1 October 

13

2004 Travel grant (Flight + accommodation +Registration fee) from Turkish 

Thoracic Society to present abstract in 7th annual meeting, 

Antalya, Turkey April 28, May 1 

2004 Travel grant (Accommodation +Registration fee+ per diem) from 

European Respiratory Society (ERS) to present abstracts in 14 th 

Annual Congress, Glasgow, UK 27 4-8 September 

2005 Travel grant (Flight + accommodation) from Oxford Health 

Alliance to participate in annual meeting in Yale University, 30 

October-1 November, New Haven ,CT 

2005 Travel grant (Flight + accommodation +Registration fee) from 

Turkish Thoracic Society to present abstracts in 8 th annual 

meeting, Antalya, Turkey April 27, May 1 

2005 Travel grant (Flight +Accommodation +Registration fee) from 

European Clinical AIDS Society for participating in European 

Advanced HIV course, Montpellier, France August 29-31 

2005 Travel grant (Flight + Accommodation) from Turkish chest 

society ( Turiye Solunum Arastirmalari Dernegi ) to talk about 

Multidrug tuberculosis treatment outcome as guest lecturer , 

Antalya, Turkey .October 19-23 

2006 Travel grant (Flight + accommodation +Registration fee + 

perdiem) from Japanese Respiratory Society to present 

abstract in 11 th Congress of the Asian Pacific society of 

Respiratory (APSR), Kyoto, Japan 19-22 November 

Patent application 

2007 I submitted Disclosure no. 07072 for a new medical instrument. It is 

under review by Office of Technology Transfer (OTT) which is 

located in the University of Louisville. This Medical instrument 

could make easier soft tissue biopsy in Tuberculosis and HIV 

patients. 

2008 I submitted Disclosure no. 07080 for a new medical instrument. It is 

under review by Office of Technology Transfer (OTT) which is 

located in the University of Louisville. This Medical instrument 

is a new tool for real-time continuous glucose monitoring in 

14

diabetic patients, using non-enzymatic electrochemical glucose 

sensor. 

Guest Lecturer/ Adjunct Professor Position 

2001 Guest lecturer in Infectious Disease and Internal Medicine 

Seminar, Islamic Azad University, Tehran, Iran, Nov 4- 8. I 

talked about Tuberculosis in this national seminar. 

2002 Guest lecturer in 10 th Iranian Congress on Infectious 

Disease & Tropical Medicine, Tehran, Iran, January 5-9. I 

talked about immunologic status in hemodialysis patients 

and diagnosis of Tuberculosis 

2002 Guest Lecturer in Respiratory Infections Conference which 

organized by Iranian General Physicians Association in 

Tehran, Iran October 16 and November 14. I talked once 

about Tuberculosis epidemiology and then about Immunity 

and Tuberculosis. 

2003 Guest lecturer in First workshop of Introduction to 

Research Methods sponsored by National Research 

Institute of Tuberculosis and Lung Disease, Tehran, Iran, 

June 29-31. I talked about different epidemiological study 

methods. 

2003 Guest lecturer in Seminar on Tuberculosis News which 

sponsored by National Research Institute of Tuberculosis 

and Lung Disease, Tehran, Iran, December 2nd. I spoke 

about new medication for short course therapy. 

2003 Guest lecturer in First International Congress of Pulmonary 

Diseases, Intensive Care and Tuberculosis, Tehran, Iran on 

December 5 th .I talked about Smoking and Tuberculosis 

relation. 

2003 Guest lecturer and member of scientific committee of Second 

Congress of Iran Virology Society, Tehran, Iran. January 1st. 

I talked about Sever Adults Respiratory Syndrome (SARS) 

2003 Invited lecturer in 16 th Congress of Pulmonary Diseases which 

sponsored by Zahedan Medical University. Zahedan, Iran on 

October 15 th -17 th . I talked about Diagnostic tools in 

Tuberculosis 

15

2003 Invited lecturer in Sever Adults Respiratory Syndrome (SARS) 

Seminar which sponsored by Iranian Virology Society, Tehran, 

Iran on May 14 th . I spoke about new mutation in Corenavirus. 

2003 Invited lecturer to on day seminar on SARS, New Disease of the 

Century which sponsored by Ardebil Branch of Azad Medical 

University, Ardebil, Iran on May 28-29. 

2004 Guest lecturer in First Conference of Tuberculosis and AIDS 

which sponsored by National Research Institute of 

Tuberculosis and Lung Disease, Tehran, Iran, June 15 th . I 

spoke about Anti-retroviral therapy in TB/HIV patients. 

2004 Guest lecturer in the workshop of AIDS & its Care & Treatment 

which sponsored by Iranian Ministry of Health, Department of 

Prevention and Combating with Tuberculosis, Tehran, Iran on 

June 23 th -25 th 

2004 Guest lecturer in Iranian College of Internal Medicine meeting. 

Tehran. Iran on December 24 th . I talked about Pneumonia. 

2005 Guest Lecturer in Seminar of Viral Hepatitis which sponsored by 

Iranian Clinical Laboratory Sciences Specialists Association, 

Tehran, Iran on March 4th. 

2005 Guest Lecturer in a week advance course on HIV and HBV 

infections which organized by Iranian Veterans affair (Janbazan 

Organization Rehabilitation Institute). I talked about pulmonary 

infection in HIV patients, Tuberculosis management and 

Multidrug resistant tuberculosis treatment. This course was 

designed for updating physicians who work with veterans. 

2005 Adjunct Professor for Semiology Course in Medicine school, 

Shaheed Beheshti University of Medical Science, Tehran, Iran. I 

spoke about history taking of pulmonary diseases patients and lung 

physical examination in several sessions in spring and fall 

semesters. 

Articles Presented in National & International Congresses 

16

1. Mirsaeidi SM, Mokhlesi Khameneh P. Evaluation of urinary tract infection in 428 

patients based on culture and sensitivity and selection of antibiotic choices. Qazvin 

University of Medical Sciences First Student Seminar, 1993. 

2. Hossein Sarmadian, Mehdi Mirsaidi, Anick Berard. Epidemiologic and 

Antibiogram Study of Cholera in 112 Patients with Positive Stool Cultures in 

Tehran, Iran. 16th International Conference on Pharmacoepidemiology Barcelona, 

Spain.August 20 st -23 rd , 2000 

3. Mirsaeidi SM, Mokhlesi Khameneh P. Cutaneous Anergy in chronic hemodialysis 

patient. Mirsaeidi SM, Valiolahpour M, Mansouri SD, et al. 2nd Annual Meeting of 

Federation of Clinical Immunology Societies USA, 2002. 

4. Mirsaeidi SM, Mohajer K, Kazempour M. Determining the ESR cutoff point and 

its role in the diagnosis of tuberculosis. National Iranian Congress of Tuberculosis, 

Zahedan, Iran, 2002. 

5. Mirsaeidi SM, Mokhlesi Khameneh P, Sarmadian H, Berard A. A study of urinary 

culture and antibiogram in Iranian children, 2nd International Meeting on 

Antimicrobial Chemotherapy in Clinical Practices (ACCP). Oct 2001, Prague, Czech 

Republic. 

6. Mirsaeidi SM, Farnia P, Masjedi MR, et al. A study on resistance to first generation 

anti-tuberculosis drugs in mycobacterium kansassii. 4th European Congress of 

Chemotherapy and Infection. May 2002. Paris, France. 

7. S. D. Mansoori, R. Noorafshar, H. R. Jamaati, H. R. Mohammadi, S. M. Mirsaeidi. 

Flowcytometric analysis of peripheral blood & pleural fluid lymphocyte subpopular 

in tuberculosis pleuritis and malignant pleural effusion. Eur Respir J 2003; 22: Suppl. 

45, 63s 

8. M. R. Masjedi, M. Amiri, S. M. Mirsaeidi, K. Mohajer, S. D. Mansouri, A. A. 

Velayati. Tuberculous bacillus drug resistance in hospitalized patients with drug 

resistant tuberculosis in Massih Daneshvari Hospital. Eur Respir J 2003; 22: Suppl. 

45, 524s. 

9. S. M. Mirsaeidi, K. Mohajer, M. Kazempour, H. R. Jamaati, S. D. Mansouri, M. R. 

Masjedi, A. A. Velayati Diagnosis and treatment delay in patients with pulmonary 

tuberculosis. Eur Respir J 2003; 22: Suppl. 45, 520s. 

10. S. M. Mirsaeidi, P. Tabarsi, M. Amiri, S. D. Mansouri, M. R. Masjedi, A. A. Velayati 

Clinical and radiologic presentations of adult tuberculous spondylitis. Eur Respir J 

2003; 22: Suppl. 45, 589s. 

17

11. M. R. Masjedi, S. M. Mirsaeidi, S. Zahirifard, K. Mohajer, M. Kazempour, M. 

Amiri, A. A. Velayati. A comparative study on serum ADA levels in cavitary and 

non-cavitary pulmonary tuberculosis patients. Eur Respir J 2003; 22: Suppl. 45, 160s. 

12. S. D. Mansouri, R. Jalali, H. R. Jamaati, M. Kazempour, S. M. Mirsaeidi. Serial 

measurement of pleural fluid ADA in tuberculous pleurisy. Eur Respir J 2003; 22: 

Suppl. 45, 160s. 

13. S. M. Mirsaeidi, M. Amiri, H. Jamaati, S. D. Mansouri, S. Shahghasempour, M. R. 

Masjedi. lveolar proteinosis, reccurrent VZV infection, TB lymphadenitis and 

Aspergillus fumigatus arthritis in idiapathic CD4 T lymphocytopenia: A case report. 

Eur Respir J 2003; 22: Suppl. 45, 45s. 

14. M. Bakhsayesh, S. M. Mirsaeidi, K. Mohajer, S. Zahirifard, M. Kazempour, M. 

Amiri, M. R. Masjedi, A. A. Velayati. Characteristics of pulmonary cavitary lesions in 

patients with pulmonary TB. Eur Respir J 2003; 22: Suppl. 45, 247s. 

15. S. Zahirifard, S. M. Mirsaeidi, K. Mohajer, M. Bakhshayeshkaram, S. D. Mansuri, M. 

R. Masjedi, A. A. Velayati CT imaging manifestations of pulmonary tuberculosis. 

Eur Respir J 2003; 22: Suppl. 45, 248s. 

16. Mirsaeidi SM, Raffiei H, Hashemi M, et al. MMPL-2 Profile in TB Patients 

compared to patients with other pulmonary disease. The World Congress on 

Psychomatic Medicine, Hawaii, USA 2003. 

17. Z. Mohammad Taheri, S. M. Mirsaeidi, A. Alvanpour, F. Mohammadi, H. R. 

Jammaati, S. D. Mansouri, A. A. Velayati. Pattern of drug resistance in bacterial 

isolates from ICU patients of Massih Daneshvari Hospital. Eur Respir J 2004; 24: 

Suppl. 48, 657s. 

18. M. S. Mirsaeidi, P. Tabarsi, M. Amiri, H. Masjedi, D. S. Mansouri, S. Zahyrifard, F. 

Mohammadi, P. Farnia, M. R. Masjedi, A. A. Velayati. Multidrug resistant 

tuberculosis (MDR – TB) treatment outcomes in Iran. Eur Respir J 2004; 24: Suppl. 

48, 657s. 

19. M. R. Bloursaz, S. Khalilzadeh, M. S. Mirsaeidi, Milani, H. Masjedi, P. Farnia, A. 

A. Velayati, M. R. Masjedi. The positive effect of oral zinc sulphate on the sputum 

smear of patients with pulmonary tuberculosis. Eur Respir J 2004; 24: Suppl. 48, 

651s. 

20. Z. Mohammad Taheri, S. M. Mirsaeidi, H. R. Jammaati, F. Mohammadi, M. Amiri, 

M. R. Masjedi, A. A. Velayati. Antibiotic sensitivity of pseudomonas aeroginosa 

isolates of respiratory secretions taken from ICU patients of the NRITLD. Eur 

Respir J 2004; 24: Suppl. 48, 641s. 

18

21. P. Tabarsi, S. M. Mirsaeidi, P. Farnia, M. Amiri, M. Bakhshayesh Karam, S. D. 

Mansouri, M. R. Masjedi, A. A. Velayati. Tuberculosis & HIV patterns in a TB 

referral center in Iran. Eur Respir J 2004; 24: Suppl. 48, 197s. 

22. A. Hirmandpour, M. S. Mirsaeidi, S. Zareiy, D. S. Mansouri, M. Kazempour, M. R. 

Masjedi.)Smoking as a risk factor mortality in pulmonary tuberculosis. Eur Respir J 

2004; 24: Suppl. 48, 191s. 

23. S. Zareiy, M. S. Mirsaeidi, D. S. Mansouri, M. Amiri, M. Kazempour, M. R. 

Masjedi, A. A. Velayati. Lymphopenia as a mortality predictor in non HIV 

pulmonary TB patients. Eur Respir J 2004; 24: Suppl. 48, 424s. 

24. S. M. Mirsaeidi, P. Farnia, F. Mohammadi, M. Kazempour, G. Kameran, M. R. 

Masjedi, A. A. Velayati. The effects of drug resistance phenotype on proliferation of 

Mycobacterium tuberculosis. Eur Respir J 2004; 24: Suppl. 48, 723s. 

24. M. R. Bloursaz, A. A. Velayati, P. Farnia, M. S. Mirsaeidi. Mycobacterium gasteri 

infection. A rare disease. Report of two cases. Eur Respir J 2004; 24: Suppl. 48, 419s. 

25. S. Tavana, D. S. Mansouri, M. S. Mirsaeidi, M. Yazdanpanah, H. Sohrabpour. The 

efficacy of interferon-alpha in treating multi-drug resistant tuberculosis. Eur Respir 

J 2004; 24: Suppl. 48, 486s. 

26. P. Tabarsi, S. M. Mirsaeidi, M. Amiri, A. Alaei, F. Mohammadi, P. Farnia, A. 

Abbasi, S. D. Mansouri, Report of a HIV patient with anal ulcer and granulomatous 

hepatitis. Eur Respir J 2004; 24: Suppl. 48, 644s. 

27. M. V. Amiri, S. Zahirifard, K. Mohajer, S. M. Mirsaeidi, M. R. Masjedi. Radiologic 

findings of multi-drug resistant pulmonary tuberculosis. Eur Respir J 2004; 24: 

Suppl. 48, 202s. 

28. Tabarsi P., Mirsaeidi S.M., Amiri M., Mansouri S.D., Masjedi M.R., Velayati A.A. 

Respiratory manifestation of HIV/AIDS patients in Iran. 3rd IAS Conference on HIV 

Pathogenesis and Treatment, Rio de Janeiro, July 24-27, 2005. 

29. Outcome of Treatment of TB/HIV patients in Iran,3rd IAS Conference on HIV 

Pathogenesis and Treatment, Rio de Janeiro, July 24-27, 2005. 

30. Seyed Mehdi Mirsaeidi, Payam Tabarsi, Zohreh MohammadTaheri, Seyed Davood 

Mansouri, Ali Akbar Velayati. [2417] BOOP as presenting manifestation of idiopathic 

hyper-eosinophilic syndrome, Eur Respir J 2005; 26: Suppl. 49 

31. Payam Tabarsi, Seyed Mehdi Mirsaeidi, Majid Amiri, Seyed Davoov Mansouri, 

Mehdi Kazempoor, Mohammad Reza Masjedi, Ali Akbar Velayati. [2704] TB in 

diabetes: typical or atypical? Eur Respir J 2005; 26: Suppl. 49 

19

32. Payam Tabarsi, Seyed Mehdi Mirsaeidi, Majid Amiri, Parvaneh Baghaei, Mehrdad 

Bakhshayeshkaram, Foruzan Mohammadi, Ali Akbar Velayati, Seyed Davood. [4070] 

Respiratory manifestation of HIV/AIDS patients in Iran Mansouri. Eur Respir J 

2005; 26: Suppl. 49 

33. Seyed Mehdi Mirsaeidi, Payam Tabarsi, Parissa Farnia, Majid Amiri, Seyed Davood 

Mansouri, Mohammad Reza Masjedi, Ali Akbar Velayati. [4124] Primary drug 

resistant mycobacterium tuberculosis in a tertiary TB center in Iran. Eur Respir J 

2005; 26: Suppl. 49 

34. Somyeh Mohammadian, J. Baghdadi, Ali Ostad Rahimi, Seyed Mehdi Mirsaeidi, 

Payam Tabarsi, Majid Amiri, Ali Akbar Velayati. [4084] Plasma level of vitamin A, E 

and C before and during pulmonary TB treatment. Eur Respir J 2005; 26: Suppl. 49 

35. Payam Tabarsi, Seyed Mehdi Mirsaeidi, Majid Amiri, Seyed Davood Mansouri, 

Parisa Farnia, Mohammad Reza Masjedi, Ali Akbar Velayati. [2906] Outcome of 

treatment of TB/HIV patients in a referral center in Iran. Eur Respir J 2005; 26: 

Suppl. 49 

36. Somayeh Mohammadian, Ali Ostad Rahimi, Jamshid Baghdadchi, Seyed Mehdi 

Mirsaeidi, Payam Tabarsi, Froozan Mohammadi, Majid Amiri, Mohammad Reza 

Masjedi, Ali Akbar Velayati. [4360] Nutritional status survey in pulmonary 

tuberculosis patients. Eur Respir J 2005; 26: Suppl. 49 

37. Seyed Mehdi Mirsaeidi, Masood Houshmand, Payam Tabarsi, Mohammad M. 

Banoei, Laleh Zargari, Majid Amiri, Seyed Davood Mansouri, Mohammad H. Sanati, Ali 

Akbar Velayati. [4149] Lack of association between interferon-Gamma receptor-1 

polymorphism and pulmonary tuberculosis in Iranian population sample. 

Eur Respir J 2005; 26: Suppl. 49 

38. Payam Tabarsi, Seyed Mehdi Mirsaeidi, Majid Amiri, Seyed Davood Mansouri, 

Mehrdad Bakhshayeshkaram, Mohammad Reza Masjedi, Ali Akbar Velayati. [2703] Is 

smear negative tuberculosis a presentation of new infection in adults? Eur Respir J 

2005; 26: Suppl. 49 

39. Mohammad Mehdi Banoei, Hasoud Houshmand, Seyed Mehdi Mirsaeidi, Bahram 

Hooshiar Kashani, Laleh Zargari, Payam Tabarsi, Majid Amiri, Seyed Davood Mansouri, 

Mohammad Sanati, Ali Akbar Velayati. [4144] Investigation of vitamin D receptor 

gene variants in Iranian patients affected with pulmonary tuberculosis. Eur Respir J 

2005; 26: Suppl. 49 

40. Masoud Houshmand, Seyed Mehdi Mirsaeidi, Mohammad Mehdi Banoei, Bahram 

Hooshiar Kashani, Laleh Zargari, Payam Tabarsi, Majid Amiri, Seyed Davood Mansouri, 

Mohammad Sanati, Mohammad Reza Masjedi. [4143] Investigation of mitochondrial 

haplogroups among Iranian patients affected with pulmonary tuberculosis. Eur 

Respir J 2005; 26: Suppl. 49 

20

41. Somayeh Mohammadiam, Seyed Mehdi Mirsaeidi, Ali Ostad Rahimi, Shapour 

Shaghasempour, Jamshid Baghdadchi, Froozan Mohammadi, Majid Amiri, Payam 

Tabarsi, Seyed Davood Mansouri, Mohammad Reza Masjedi. [4147] Evaluation of 

vitamine A supplement-therapy on immunologic profiles of pulmonary tuberculosis 

patients. Eur Respir J 2005; 26: Suppl. 49 

42. Majid V. Amiri, S. Davoud Mansouri, S. Mehdi Mirsaeidi, Payam Tabaresi, 

Mohammadreza Masjedi. [2657] Evaluation of the combined use of polymerase chain 

reaction (PCR) and adenosine deaminase (ADA) activity on the diagnosis of pleural 

tuberculosis. Eur Respir J 2005; 26: Suppl. 49 

43. Seyed Mehdi Mirsaeidi, Payam Tabarsi, 1 Majid Amiri, Seyed Davood Mansouri, 

Mehdi Kazempour, Mohaam Reza Masjedi, Ali Akbar Velayati. [1026] Tobacco 

smoking and pulmonary tuberculosis; interactions from clinic to laboratory. Eur 

Respir J 2005; 26: Suppl. 49 

44. Farnoosh Hashemian, Tan Jibin, Jianjun Liu, K.R. Thankappan, Thresia.C.U., 

Achutha Menon Sree Chitra Tirunal, Seyed Mehdi Mirsaeidi, Jorge A. Ramirez Andrey 

Demin, Reducing Deaths from Tuberculosis and Tobacco Together, 4th Annual 

Global Health Research Conference, March 2006, Toronto University, Canada 

45. Ebrahimi G , Mirsaeidi SM , Lowlaavar N , Tabarsi P , Shariat Z , Amiri M , 

Khosravani A , Mohammadi F , Mansouri D Seroepidemiology of Herpes Virus 8 in 

Hiv Positive Patients in a Hiv Center in Iran (Preliminary Report). 16th International 

AIDS Conference; 8/13/2006 to 8/19/2006; Toronto; Canada 

46. Tabarsi P , Mirsaeidi SM , Mohammadi F , Ebrahimi G , Mansouri D , Velayati AA , 

HIV study group, Hbv & Hcv Viruses and Hiv Co-Infection in Iranian Patients. 16th 

International AIDS Conference; 8/13/2006 to 8/19/2006; Toronto; Canada 

47. P. Tabarsi, N. Hemmati, M. Mirsaeidi, M. Amiri, P. Farnia, P. Baghai, D. Mansouri, 

M. R. Masjedi, A. A. Velayati. Evaluation of therapeutic response in isoniazid 

resistant TB. Eur Respir J 2006; 28: Suppl. 50, 846s 

48. M. V. Amiri, M. Mirsaeidi, P. Tabaresi, D. Mansouri, M. Masjedi, K. Kiahashemi, 

A. Velayati . Secondary drug resistance tuberculosis in Iran. Eur Respir J 2006; 28: 

Suppl. 50, 586s 

49. P. Tabarsi, M. Mirsaeidi, A. Nooraki, M. Amiri, M. Kazempour, D. Mansouri, M. R. 

Masjedi, A. A. Velayati. Pattern of drug resistance among patients who fail Cat II 

regimen and patients who fail standard treatment: is there any difference? Eur 

Respir J 2006; 28: Suppl. 50, 378s 

21

50. D. Mansouri, P. Adimi, M. Mirsaeidi, P. Adimi, J. L. Casanova, M. R. Masjedi. 

Inherited disorders of the IL-12-INF-gamma axis in patients with disseminated 

BCG infection.Eur Respir J 2006; 28: Suppl. 50, 312s 

51. D. Faridian Eragh, S. Falah Tafti, M. Marashian, S. M. Mirsaeidi, M. Kazempoor 

Dizaji. Short outcome and evaluation of hemoptysis in patients with old pulmonary 

TB.Eur Respir J 2006; 28: Suppl. 50, 10s 

52. P. Tabarsi, P. Baghaei, H. Emami, M. Mirsaeidi, M. Amiri, D. Mansouri, M. R. 

Masjedi. Outcomes of individualized treatment for MDR TB in Iran. 17th Annual 

Congress of the European Respiratory Society (ERS) 9/15/2007 to 9/19/2007; Stockholm; 

Sweden 

53. P. Tabarsi, P. Baghaei, M. Mirsaeidi, M. Amiri, M. R. Masjedi. Comparison of the 

efficacy of two methods of treatment, standard and modified, on patients with 

Isoniazid resistant tuberculosis. 17th Annual Congress of the European Respiratory Society 

(ERS) 9/15/2007 to 9/19/2007; Stockholm; Sweden 

54. P. Tabarsi, A. Nooraki, P. Baghaei, M. Mirsaeidi, M. Amiri, D. Mansouri, M. R. 

Masjedi. Representative drug susceptibility patterns for guiding design of 

retreatment regimens for MDR – TB in Iran. . 17th Annual Congress of the European 

Respiratory Society (ERS) 9/15/2007 to 9/19/2007; Stockholm; Sweden 

55. Tabarsi P, Baghaei P, Mirsaeidi M, Amiri M, Masjedi M-R.Comparison of the 

Efficacy of Two Methods of Treatment, Standard and Modified, on Patients with 

Isoniazid Resistant Tuberculosis. 17th Annual Congress of the European Respiratory 

Society (ERS) 9/15/2007 to 9/19/2007; Stockholm; Sweden 

56. Tabarsi P,Mirsaeidi M, Yadegarinia D, Masjedi MR. Representative drug 

susceptibility patterns for guiding design of retreatment regimens for MDR-TB in 

IRAN. 45th ANNUAL MEETING OF IDSA, OCTOBER 4 – 7, 2007 SAN DIEGO. 

57. Julio Ramirez,MD, Stefano Aliberti, MD, Mehdi Mirsaeidi, MD, Paula Peyrani, MD 

Giovanni Filardo, PhD,Gur Levy,MD, Patricia Fernandez, MD, Delfino Legnani, MD, 

Marilyn Mateo,MD, Maria Bodi, MD, Jorge Martinez, MD, Francesco Blasi, MD and the 

CAPO Investigators. Acute myocardial infarction in hospitalized patients with 

community-acquired pneumonia: results from the CAPO international cohort 

study. European Respiratory Society, Annual Congress, Berlin, Germany: October 4-8, 

2008 

58. Mehdi Mirsaeidi MD, Paula Peyrani MD, Stefano Aliberti MD, Giovanni Filardo 

PhD, Francesco Blasi MD, Harmut Lode MD, Juan Manuel Luna MD, Maria Teresa 

Parada, MD, Julio Ramirez MD and the CAPO Investigators. Thrombocytosis predicts 

poor outcomes in patients with community-acquired pneumonia: results from the 

CAPO international cohort study. European Respiratory Society, Annual Congress, 

Berlin, Germany: October 4-8, 2008 

22

59. Mehdi Mirsaeidi MD, Paula Peyrani MD, Jessica PortilloMD , Marty Allen MD, 

Federico Arteta MD, Jose Porras MD, Jorge Roig MD, Eduardo Rodriguez, MD, Maria 

Rodriguez, MD, Julio Ramirez MD and the CAPO Investigators. Female gender is 

associated with poor clinical outcomes in hospitalized patients with communityacquired 

pneumonia: results from the CAPO international cohort study. European 

Respiratory Society, Annual Congress, Berlin, Germany: October 4-8, 2008 

60. Mehdi Mirsaeidi MD, Paula Peyrani MD, Alejandro Diaz Fuenzalida MD, Jose 

Gonzalez MD, Lucia Marzoratti MD, Ivan Toala MD, Ludwig Rivero MD, Julio Ramirez 

MD and the CAPO Investigators. Penicillin-resistant streptococcus pneumoniae is a 

rare etiology of community-acquired pneumonia requiring hospitalization: results 

from the CAPO international cohort study. European Respiratory Society, Annual 

Congress, Berlin, Germany: October 4-8, 2008 

61. Mehdi Mirsaeidi MD, Jessica Portillo MD, Ervin Anaya MD, Paula Peyrani MD, 

Juan Guardiola MD, Forest Arnold MD, Raul Nakamatsu MD, Carlos Victorio MD, 

Gonzalo AielloMD, Mario Perez Mirabal MD, Julio Ramirez MD and the CAPO 

Investigators. Pleural effusion predicts poor outcomes in hospitalized patients with 

community-acquired pneumonia: results from the CAPO international cohort 

study. European Respiratory Society, Annual Congress, Berlin, Germany: October 4-8, 

2008 

62. Miandehi, N., Shekarabi, M, Mansoori, D, Kheiri, M. T, Mirsaeedi, M. The study of 

TH1 and TH2 cytokines profile (FN gamma,IL-12, IL-4, IL-10) in PBMCs of patients 

with MDR-TB and newly diagnose treated cases tuberculosis. Infection Genetics and 

Evolution, 2008. 8(4): p. S40-S40. 

63. Mehdi Mirsaeidi MD, Paula Peyrani MD, Julio Ramirez MD.Predicting Mortality 

in Patients with Ventilator-Associated Pneumonia: The APACHE II score versus 

the new IBMP-10 score. Results from the IMPACT-HAP Study. 48th Annual 

ICAAC/IDSA 46 th Annual Meeting. Washington DC Oct. 25-28 2008 

64. Mehdi Mirsaeidi MD, Paula Peyrani MD, Julio Ramirez MD. Making the 

Microbiological Diagnosis in Patients with Healthcare-Associated Pneumonia, 

Hospital-Acquired Pneumonia, and Ventilator-Associated Pneumonia: Role of 

Bacteremia. Results from the IMPACT-HAP Study. 48th Annual ICAAC/IDSA 46 th 

Annual Meeting. Washington DC Oct. 25-28 2008 

65. P. PEYRANI, T. WIEMKEN, M. MIRSAEIDI, M. GNONI, J. RAMIREZ, And The 

Impact-hap Study Group; Variability of Hospital Cost for Patients with Ventilator- 

Associated Pneumonia: Results from the IMPACT-HAP Study. 48th Annual 

ICAAC/IDSA 46 th Annual Meeting. Washington DC Oct. 25-28 2008 

66. M. ALLEN, M. MIRSAEIDI , P. PEYRANI , J. MANGINO , M. ZERVO,D. KETT 

, K. FORD , E. SCERPELLA , J. RAMIREZ , And The Impact-hap Study Group; 

23

Emergence of Community-Associated Methicillin Resistant Staphylococcus aureus 

as Etiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: 

Results from the IMPACT HAP Study. 48th Annual ICAAC/IDSA 46 th Annual 

Meeting. Washington DC Oct. 25-28 2008 

67. RAUL NAKAMATSU, MD, MEHDI MIRSAEIDI, MD, PAULA PEYRANI, MD, 

FOREST ARNOLD, DO, JULIO RAMIREZ, MD, the CAPO Investigators; Pleural 

Effusion Predicts Poor Outcomes in Hospitalized Patients with Community- 

Acquired Pneumonia: Results from the CAPO International Cohort Study. 47th 

Annual IDSA Meeting. October 29 - November 1, 2009, Philadelphia, Pennsylvania 

68. RAUL NAKAMATSU, MD, MEHDI MIRSAEIDI, MD, PAULA PEYRANI, MD, 

FOREST ARNOLD, DO, MARTY ALLEN, MD, JULIO RAMIREZ, MD, the CAPO 

Investigators; Influence of Age in the Mortality of Elderly and Very Elderly Patients 

Hospitalized with Community-Acquired Pneumonia: Results from the CAPO 

International Cohort Study. 47th Annual IDSA Meeting. October 29 - November 1, 

2009, Philadelphia, Pennsylvania 

69. RAUL NAKAMATSU, MD, BRYAN MOFFETT, MD, ERVIN ANAYA, MD, 

MEHDI MIRSAEIDI, MD, FOREST ARNOLD, DO, PAULA PEYRANI, MD, JULIO 

RAMIREZ, MD; Imaging Studies To Define the Need for Aspiration of Para- 

Pneumonic Effusions in Hospitalized Patients with Community-Acquired 

Pneumonia. 47th Annual IDSA Meeting. October 29 - November 1, 2009, 

Philadelphia, Pennsylvania 

70. FOREST ARNOLD, DO, RAUL NAKAMATSU, MD, MEHDI MIRSAEIDI, MD, 

ERVIN ANAYA, MD, BRYAN MOFFETT, MD, PAULA PEYRANI, MD, JULIO 

RAMIREZ, MD; Evaluation of the Management of Para-Pneumonic Effusions in 

Hospitalized Patients with Community-Acquired Pneumonia. 47th Annual IDSA 

Meeting. October 29 - November 1, 2009, Philadelphia, Pennsylvania 

71. SCOTT SMITH, R. Ph, DAVID NEWMAN, R. Ph, MEHDI MIRSAEIDI, MD, 

PAULA PEYRANI, MD, TIMOTHY WIEMKEN, MPH, JULIO RAMIREZ, MD, the 

CAPO Investigators; Early Antibiotic Administration Does Not Decrease Mortality in 

Hospitalized Patients with Community-Acquired-Pneumonia: Results from the 

CAPO International Cohort Study. 47th Annual IDSA Meeting. October 29 - 

November 1, 2009, Philadelphia, Pennsylvania 

24

Translations 

Yazdi Nejad A, Sadat Afsari F, Masroor Shalmani F. Danforth’s obstetrics and 

Gynecology. Mir publications, 2001.The original title: Danforths obstetrics and 

Gynecology 8 th ed. 1999 Danfarth D- Scott JR 

Books 

1. Mirsaeidi SM, Amiri M. (Lung) Auscultation. (Under publication) 

2. Mirsaeidi SM, Amiri M, SARS, NRITLD publication, 2004. 

3. Mirsaeidi SM. Respiratory infections in children with HIV infection. Text book of 

pediatric respiratory diseases, Shaheed Beheshti University of Medical Sciences, 2004. 

Recent Projects 

1. Evaluation of secretory capacity in peripheral blood monocytes of IL-4, IL-12, IFN in 

resistant, cases non- resistant new cases, and miliary cases of tuberculosis. 

2. Incidence of serious side effects from first line anti tuberculosis drugs among patients 

treated for active tuberculosis in Masih Daneshvari hospital. 

3. Effect of Vitamin A, E and C supplementation on Oxidative stress and immunologic 

profile of Tuberculosis patients. 

4. Study of seroepidemiology of Herpes Virus 8 in HIV positive patients in Masih 

Daneshvari Hospital 2004-5 

5. Relation between Tobacco & tuberculosis in Massih Daneshvari Hospital. 

6. Polymorphism and genetic sequencing of IFN-gamma R1, VDR, NRAMP1, 

HLADRB, DNA and IL12p40 mitochondrial haplogroup in smear positive hospitalized 

TB patients and non-tuberculosis patients: a comparative study. 

7. Study on subtype & resistant pattern of Human immunodeficiency Virus (HIV) in Iran 

25

8. The effect of first line anti- tuberculosis drug resistance on mycobacterium 

tuberculosis proliferation. 

9. Immunologic status of smoker and non-smoker tuberculosis patients, a comparative 

study. 

10. Lymphocyte sub-populations and lymphocyte activation markers activity in 

tuberculosis patients comparing to normal population of Iran. 

11. 11. Role of Myocardial Infarction in failure of Community Acquired Pneumonia 

12. PVL-MRSA as a new pathogen in Hospital Acquired Pneumonia. 

Other 

Invited review article titled as “Community Acquired Pneumonia and Myocardial 

Infarctions; New Concepts, New Approach” in Arab Health Magazine (Dubai, United 

Arab Emirates) 2008 

Editing serial articles with the following titles in several volumes of weekly periodical of 

pezeshki Emrooz (Iranian Medical Magazine) during years: 1998-2000. Titles: Lung 

cancer epidemiology, Botulism, Cholera: A horrifying disease and Typhoid (Enteric) 

fever. 

http://www.researcherid.com/rid/A-6448-2008 

26

CURRICULUM VITAE - University of Illinois College of Medicine at ...

Create successful ePaper yourself

Delete template?

Save as template?